Yarrow Bioscience (YARW) Finished Goods (2021)
Yarrow Bioscience's (YARW) quarterly Finished Goods came in at $4.0 million in Q4 2021.
Yarrow Bioscience (YARW) Finished Goods (2021) Analysis & Trends
Yarrow Bioscience (YARW) has 1 years of Finished Goods data on file, last reported at $4.0 million in Q4 2021.
- Quarterly Finished Goods changed N/A year-over-year to $4.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $4.0 million (changed N/A YoY) and the FY2021 annual result came in at $4.0 million, changed N/A from the prior year.
- Finished Goods was little changed at $4.0 million in Q4 2021.
- In the past five years, Finished Goods ranged from a high of $4.0 million in Q4 2021 to a low of $4.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Yarrow Bioscience | 31.01 Mn | 8.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.00 Mn |